Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Cholesteryl ester transfer protein polymorphism (TaqIB) associates with risk in postinfarction patients with high C-reactive protein and high-density lipoprotein cholesterol levels.

Corsetti JP, Ryan D, Rainwater DL, Moss AJ, Zareba W, Sparks CE.

Arterioscler Thromb Vasc Biol. 2010 Aug;30(8):1657-64. doi: 10.1161/ATVBAHA.110.207977. Epub 2010 May 20.

2.

Increased coronary heart disease risk determined by high high-density lipoprotein cholesterol and C-reactive protein: modulation by variation in the CETP gene.

Dullaart RP.

Arterioscler Thromb Vasc Biol. 2010 Aug;30(8):1502-3. doi: 10.1161/ATVBAHA.110.209544. No abstract available.

3.

LPL polymorphism (D9N) predicts cardiovascular disease risk directly and through interaction with CETP polymorphism (TaqIB) in women with high HDL cholesterol and CRP.

Corsetti JP, Gansevoort RT, Navis G, Sparks CE, Dullaart RP.

Atherosclerosis. 2011 Feb;214(2):373-6. doi: 10.1016/j.atherosclerosis.2010.11.029. Epub 2010 Nov 26.

4.

An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study.

Borggreve SE, Hillege HL, Wolffenbuttel BH, de Jong PE, Zuurman MW, van der Steege G, van Tol A, Dullaart RP; PREVEND Study Group..

J Clin Endocrinol Metab. 2006 Sep;91(9):3382-8. Epub 2006 May 9.

PMID:
16684835
5.

Plasminogen activator inhibitor-2 polymorphism associates with recurrent coronary event risk in patients with high HDL and C-reactive protein levels.

Corsetti JP, Salzman P, Ryan D, Moss AJ, Zareba W, Sparks CE.

PLoS One. 2013 Jul 9;8(7):e68920. doi: 10.1371/journal.pone.0068920. Print 2013.

6.

Thrombospondin-4 polymorphism (A387P) predicts cardiovascular risk in postinfarction patients with high HDL cholesterol and C-reactive protein levels.

Corsetti JP, Ryan D, Moss AJ, McCarthy J, Goldenberg I, Zareba W, Sparks CE.

Thromb Haemost. 2011 Dec;106(6):1170-8. doi: 10.1160/TH11-03-0206. Epub 2011 Oct 20.

PMID:
22011848
7.

HDL cholesterol and TaqIB cholesteryl ester transfer protein gene polymorphism in renal transplant recipients.

Radeau T, Vohl MC, Houde I, Lachance JG, Noël R, Després JP, Douville P, Bergeron J.

Nephron. 2000 Apr;84(4):333-41.

PMID:
10754410
8.

Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study.

Ordovas JM, Cupples LA, Corella D, Otvos JD, Osgood D, Martinez A, Lahoz C, Coltell O, Wilson PW, Schaefer EJ.

Arterioscler Thromb Vasc Biol. 2000 May;20(5):1323-9.

9.

The -629C>A polymorphism in the CETP gene does not explain the association of TaqIB polymorphism with risk and age of myocardial infarction in Icelandic men.

Eiriksdottir G, Bolla MK, Thorsson B, Sigurdsson G, Humphries SE, Gudnason V.

Atherosclerosis. 2001 Nov;159(1):187-92.

PMID:
11689220
10.

A novel cholesteryl ester transfer protein promoter polymorphism (-971G/A) associated with plasma high-density lipoprotein cholesterol levels. Interaction with the TaqIB and -629C/A polymorphisms.

Le Goff W, Guerin M, Nicaud V, Dachet C, Luc G, Arveiler D, Ruidavets JB, Evans A, Kee F, Morrison C, Chapman MJ, Thillet J.

Atherosclerosis. 2002 Apr;161(2):269-79.

PMID:
11888509
11.

The association between high-density lipoprotein cholesterol level and cholesteryl ester transfer protein TaqIB gene polymorphism is influenced by alcohol drinking in a population-based sample.

Tsujita Y, Nakamura Y, Zhang Q, Tamaki S, Nozaki A, Amamoto K, Kadowaki T, Kita Y, Okamura T, Horie M, Ueshima H.

Atherosclerosis. 2007 Mar;191(1):199-205. Epub 2006 May 3.

PMID:
16674961
12.

Polymorphism in the CETP gene region, HDL cholesterol, and risk of future myocardial infarction: Genomewide analysis among 18 245 initially healthy women from the Women's Genome Health Study.

Ridker PM, Paré G, Parker AN, Zee RY, Miletich JP, Chasman DI.

Circ Cardiovasc Genet. 2009 Feb;2(1):26-33. doi: 10.1161/CIRCGENETICS.108.817304. Epub 2009 Jan 23.

14.

Cholesteryl ester transfer protein gene haplotypes, plasma high-density lipoprotein levels and the risk of coronary heart disease.

McCaskie PA, Beilby JP, Chapman CM, Hung J, McQuillan BM, Thompson PL, Palmer LJ.

Hum Genet. 2007 May;121(3-4):401-11. Epub 2007 Feb 8.

PMID:
17287950
15.

Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population.

Corella D, Sáiz C, Guillén M, Portolés O, Mulet F, González JI, Ordovás JM.

Atherosclerosis. 2000 Oct;152(2):367-76.

PMID:
10998464
16.

A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men.

Liu S, Schmitz C, Stampfer MJ, Sacks F, Hennekens CH, Lindpaintner K, Ridker PM.

Atherosclerosis. 2002 Apr;161(2):469-74. Erratum in: Atherosclerosis. 2003 Feb;166(2):415.. Liu Simm [corrected to Liu Simin].

PMID:
11888533
17.

Genetic variation in cholesterol ester transfer protein, serum CETP activity, and coronary artery disease risk in Asian Indian diabetic cohort.

Schierer A, Been LF, Ralhan S, Wander GS, Aston CE, Sanghera DK.

Pharmacogenet Genomics. 2012 Feb;22(2):95-104. doi: 10.1097/FPC.0b013e32834dc9ef.

18.
19.

Association of cholesteryl ester transfer protein activity and TaqIB polymorphism with lipoprotein variations in Japanese subjects.

Ikewaki K, Mabuchi H, Teramoto T, Yamada N, Oikawa S, Sasaki J, Takata K, Saito Y; Japan CETP Study Group..

Metabolism. 2003 Dec;52(12):1564-70.

PMID:
14669156
20.

Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.

Kappelle PJ, Gansevoort RT, Hillege HJ, Wolffenbuttel BH, Dullaart RP; PREVEND Study Group..

J Clin Lipidol. 2013 Jan-Feb;7(1):56-64. doi: 10.1016/j.jacl.2012.05.003. Epub 2012 May 22.

PMID:
23351584

Supplemental Content

Support Center